ISHI Health, an AI-powered virtual clinic based in San Diego, specializing in heart failure and complex cardiac disease care, has secured $4 million in funding. This investment, led by Takeda Digital Ventures (TDV), marks a significant milestone for ISHI Health as it aims to transform heart failure care across the disease risk spectrum.

Cardiovascular disease remains a leading cause of death and disability globally, with heart failure syndrome affecting over 6 million people in the United States alone. Recognizing this pressing need, ISHI Health has developed innovative solutions to revolutionize cardiac care delivery.

The funding will fuel ISHI’s expansion efforts, enabling the company to broaden its product range, enter new markets, and enhance clinical outcomes and patient experiences. Dr. Ajay Srivastava, founder of ISHI Health and an Advanced Heart Failure cardiologist, emphasized the company’s commitment to understanding and addressing pain points in cardiac care.

“Our journey began with a commitment to understand and address pain points in cardiac care, starting with heart failure patients,” said Dr. Srivastava. “Through the integration of technology and AI, we’re able to provide patients with unprecedented convenience and proactive care, ensuring better outcomes and enhanced patient experiences.”

At the core of ISHI’s strategy is a collaborative partnership with patients’ primary cardiologists, enabling care teams to deliver quality heart failure care locally in their communities. By leveraging AI algorithms and connected devices, ISHI provides personalized care tailored to each patient’s unique heart disease profile, biometric data, and symptoms.

Through its participation in Mayo Clinic Platform_Accelerate, ISHI Health has developed a virtual care program that utilizes a platform to analyze patients’ biometric data gathered from various external and implanted cardiac sensors. This approach allows ISHI to offer precision care across the entire cardiac risk spectrum.

“We surpass traditional care approaches by offering proactive recommendations customized to each patient’s needs,” explained Dr. Srivastava. “Our holistic approach optimizes patient outcomes by coordinating care among various healthcare team members, ensuring comprehensive support throughout the patient journey.”

ISHI Health’s dedication to providing high-quality heart failure care in rural and suburban areas has been recognized with the prestigious AWS Health Equity award, highlighting the company’s commitment to addressing healthcare disparities and delivering exceptional care to underserved communities.

Suzie Yoon, Investor at TDV, expressed enthusiasm about the partnership, stating, “At TDV, we are dedicated to identifying advanced capabilities that improve patient outcomes and experience. ISHI stands out by integrating AI, virtual, and remote functionalities, offering an innovative hybrid care solution with the potential to benefit a broad spectrum of patients.”

With the recent funding secured, ISHI Health is poised for expansion. Over the next year, the company aims to expand its clinical operations, forge partnerships with more provider groups, and enter new markets. ISHI is committed to showcasing superior clinical outcomes and patient experiences while collaborating with payors on value-based care initiatives tailored for heart failure and complex cardiac patients.

For more information about ISHI Health and its revolutionary approach to heart failure care, visit www.ishi.health.